SCHEMBL3347865

SCHEMBL3347865

Cc1ccc(-c2ccc(C)c(N)c2)nn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
TDP1 Q9NUW8 3/20 0.42
CASP1 P29466 1/20 0.42
RAB9A P51151 3/20 0.41
TSHR P16473 3/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP11B1 P15538 1/20 0.41
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 2/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
CYP3A4 P08684 2/20 0.39
LMNA P02545 1/20 0.39
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342892 0.81 MAPT (0.46) ALDH1A1TDP1CASP1RAB9ATSHR
SCHEMBL17051575 0.77 NPC1 (0.44) ALDH1A1RAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL10996289 0.75 AURKB (0.51) ALDH1A1CASP1TSHRHSD17B10KDM4E
SCHEMBL3347858 0.75 P2RX7 (0.44) TDP1CASP1P2RX7
SCHEMBL31661348 0.75 CYP3A4 (0.62) ALDH1A1TDP1CASP1RAB9ATSHR
SCHEMBL6866139 0.75 CYP3A4 (0.62) ALDH1A1TDP1CASP1RAB9ATSHR
SCHEMBL22199144 0.74 MEN1 (0.42) RAB9ANPC1SLC6A2SLC6A4SLC6A3
SCHEMBL23153776 0.74 P2RX7 (0.36) ALDH1A1TDP1TSHRHSD17B10KDM4E
SCHEMBL3342851 0.73 CYP11B1 (0.46) ALDH1A1TDP1CASP1RAB9ATSHR
SCHEMBL3342956 0.73 CYP11B1 (0.52) ALDH1A1TDP1CASP1RAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 ALDH1A1 1506/4885TDP1 1578/4885CASP1 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.